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Abstract
Endometrial regeneration is mediated, at least in part, by the existence of a specialized somatic stem cell (SSC) population
recently identified by several groups using the side population (SP) technique. We previously demonstrated that
endometrial SP displays genotypic, phenotypic and the functional capability to develop human endometrium after
subcutaneous injection in NOD-SCID mice. We have now established seven human endometrial SP (hESP) cell lines (ICE 1–7):
four from the epithelial and three from the stromal fraction, respectively. SP cell lines were generated under hypoxic
conditions based on their cloning efficiency ability, cultured for 12–15 passages (20 weeks) and cryopreserved. Cell lines
displayed normal 46XX karyotype, intermediate telomerase activity pattern and expressed mRNAs encoding proteins that
are considered characteristic of undifferentiated cells (Oct-4, GDF3, DNMT3B, Nanog, GABR3) and those of mesodermal
origin (WT1, Cardiac Actin, Enolase, Globin, REN). Phenotype analysis corroborated their epithelial (CD9+) or stromal
(vimentin+) cell origin and mesenchymal (CD90+, CD73+ and CD452) attributes. Markers considered characteristic of
ectoderm or endoderm were not detected. Cells did not express either estrogen receptor alpha (ERa) or progesterone
receptor (PR). The hESP cell lines were able to differentiate in vitro into adipocytes and osteocytes, which confirmed their
mesenchymal origin. Finally, we demonstrated their ability to generate human endometrium when transplanted beneath
the renal capsule of NOD-SCID mice. These findings confirm that SP cells exhibit key features of human endometrial SSC and
open up new possibilities for the understanding of gynecological disorders such as endometriosis or Asherman syndrome.
Our cell lines can be a valuable model to investigate new targets for endometrium proliferation in endometriosis.
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Introduction
The existence of somatic stem cells (SSC) in the human and
murine endometrium has been postulated and attributed to a
particular subpopulation of mesenchymal origin located in the
basal layer [1–16]. Nevertheless, the main limitation of these
studies is the absence of specific markers that identify the
endometrial SSC population.
The side population (SP) phenotype was first described in bone
marrow where a somatic stem cell population was identified based
on the ability of these cells to extrude the DNA binding dye,
Hoechst 33342 [17] a phenomenon associated with the expression
of an ATP binding cassette transported encoded by the breast
cancer resistance protein gene (BCRP1/ABCG2) [18]. In general,
the SP phenotype is thought to be a universal marker of somatic
stem cells and has been used to isolate them from many adult
tissues, such as the mammary gland, skin, myometrium, lung and
dental pulp [19–23]. Accumulated evidence has suggested that the
endometrial SP population could represent, at least in part, the
SSC population in this particular tissue [24–27]. Functional proof
of concept has been demonstrated by the ability of endometrial SP
to reconstruct human endometrium after subcutaneous injection
[26] or transplantation under the kidney capsule [27] in NOD-
SCID mice. Nevertheless, the efficiency of this endometrium
reconstruction is very low, as only two cases from the total of 24
injected animals [27] and one out of 50 [26] were successful.
To further explore our previous finding [26], the aim of the
present study was to establish and characterize human endome-
trial SP cell lines from the epithelial and stromal compartments
providing a model system for studies on human endometrial SSC.
Methods
Ethics statement
This study was approved by the Institutional Review Board and
Ethics Committee of Instituto Universitario-IVI (Universidad de
Valencia, Spain), and informed written consent was obtained from
each patient prior to tissue collection. Procedures performed on
animals were also approved by CIPF and Instituto Valenciano de
Infertilidad (IVI) review boards (Animal ethical Committee 08/0065).
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Human tissue collection
Human endometrium from healthy women was obtained from
endometrial biopsies using a Pipelle sampler (Genetics, Namont-
Achel, Belgium) under sterile conditions.
Epithelial and stromal separation
Endometrial biopsies were disaggregated by mechanical and
enzymatic means in order to obtain single cell suspensions. Then,
epithelial and stromal single cells were isolated from human
endometrial tissue using established protocols [26,28]. Cell suspen-
sions were also treated with erythrocyte lysis solution (ammonium
chloride, potassium bicarbonate, tetrasodium ethylene-diaminete-
traacetic acid (EDTA)) to avoid red blood cell contamination by
hypotonic shock, and evaluation of cell viability was performed with
Propidium Iodide (PI; 5 mg/ml,Sigma-Aldrich, Spain).
Flow cytometry and side population isolation
Epithelial and stromal cell suspensions were labeled with 10 mg/
ml of Hoechst 33342 dye (Sigma-Aldrich, Spain) either alone or in
combination with 50 mM verapamil (Sigma-Aldrich, Spain) in
order to obtain Side Population cells, according to a previously
described protocol [26]. Labeled cells were analyzed and sorted by
a MoFloH (Dako, Denmark, http://www.dako.com) jet-in-air
high-speed sorter as described previously by Cervello´ et al., 2010
[26]. The gates for cell sorting were defined to collect live cells
with a low Hoechst 33342 fluorescence (SP fraction), as well as live
cells with a high Hoechst 33342 fluorescence (NSP fraction).
Cell culture and generation of cell lines
Cell lines generated were established in several steps. Briefly, the
human endometrial SP cells from epithelial and stromal fractions
isolated by flow cytometry were plated at clonal density (20–200
cells/cm2) and cultured in DMEM F-12 (Invitrogen, Spain)
containing 10% of fetal bovine serum (FBS), glutamine 2 mM
(Sigma-Aldrich, Spain), and antibiotic-antimycotic solution (Am-
photericin B-Gentamicin). These cells were maintained at 37uC in
hypoxic conditions (1–2% O2). Two weeks after seeding, the
largest individual primary clones derived from single cells were
selected, picked, and re-plated to generate secondary clones. After
an additional two weeks in culture, secondary clones were picked
and re-cloned to generate tertiary clones. At the fourth and
following passages, cells reached 80–100% confluence. Serial cell
culture continued in this manner through 12–15 passages.
Immunophenotypic characterization
Once the putative epithelial and stromal somatic stem cell lines
were established, a preliminary characterization was necessary to
confirm purity, origin, and features of the generated cell lines.
Analysis was assessed by the staining with typical antibodies: CD9
for epithelial cells; vimentin for stromal cells; CD90, CD73, and
CD105 for mesenchymal stem cells; CD34 and CD45 for
hematopoietic stem cells; CD31 for endothelial cells; Stro-1 for
bone marrow stromal cells, and CD133 for endothelial progenitor
cells (antibodies are detailed in supporting information Table S1).
Immunophenotypic analysis was performed in a Cytomics FC500
flow cytometer (Beckman-Coulter, CA, USA).
RNA isolation and reverse transcription
Total RNA extraction was performed by two methods
depending on the desired outcome. For molecular characteriza-
tion, RNA was extracted from cell cultures using the Mini RNA
Isolation I Kit according to the manufacturer’s protocol (Zymo,
Irvine, CA 92614, U.S.A.). In addition, the TRIzol method was
used in order to assess differentiation results (Life Technologies
Inc., Gaithersburg, MD). In both cases, one mg of RNA was used
for cDNA synthesis with the Reverse Transcription System
(Clontech, Palo Alto, CA, USA).
PCR for undifferentiated and differentiated markers
A semiquantitative PCR was performed for typical undifferen-
tiated and differentiated markers in order to characterize the cell
lines. The primers used are listed in the Table 1 (list of primers
used for cell line characterization). GAPDH expression was used as
a housekeeping gene for normalization.
The molecular analyses of these genes were carried out in ICEp
and ICEs cell lines. Human embryonic stem cell (hESC) line VAL-
9 [29] was used as a positive control for undifferentiated markers
and diverse tissues (heart, kidney, etc.) were used to test
mesodermal origin. PCR was carried out using a BIOMETRA
thermal cycler, with the following conditions 59uC and 30 cycles.
Finally, the PCR products were run on a 2% agarose
electrophoresis gel.
Karyotype
In passage 8 to 9, the cells were treated with culture medium
containing colchicine (KaryoMAXHColcemidTM solution, Invitro-
gen) for 30 minutes and treated with hypotonic buffer 0.075 M
KCl (Potassium Chloride, Invitrogen) during 15 minutes. Cell
suspensions were fixed in 3:1 methanol-acetic acid and air-dried.
Finally cells were stained with 49,6-diamidino-2-phenylindole
(DAPI, Invitrogen) to performed cytogenetic analysis.
Telomerase activity
Telomerase activity was analyzed using the TRAPEZEH
Telomerase Detection Kit (Chemicon), and further staining was
performed with SYBRH Green I (Molecular probes). Briefly,
cultured cells (100,000 cells) were harvested, washed once in Ca2+/
Mg2+-free PBS, and were immediately resuspended in lysis buffer.
After treatment on ice and spinning at high speed, samples were
subjected to a PCR reaction following the manufacturer’s
instructions. PCR products were run in polyacrylamide gel
(BioRad) under non-denaturing conditions and amplified frag-
ments were then stained with SYBR green for visualization in a
transilluminator. Each experiment included the human embryonic
stem cell line, VAL-9 as a positive control, and foreskin (somatic
cell line) as a negative control.
Estrogen and progesterone receptor expression
To investigate the expression of estrogen receptor alpha (ERa)
and progesterone receptor (PR) in human endometrial SSC lines
(ICEp and ICEs), cytospins were made from the cell suspensions
and fixed in 90% acetone/10% methanol. Cytospins of the human
breast adenocarcinoma MCF-7 (ATCC reference HTB22) and
estrogen-treated human endometrial adenocarcinoma Ishikawa
(ISH) (ECACC reference 99040201) cell lines served as positive
controls for ERa and PR antibodies, respectively. Immunocyto-
chemistry was performed as follows: endogenous peroxidase was
blocked using a solution of 0.15% H2O2 (Fisher Scientific,
Leicestershire, UK) in methanol before permeabilizing the cytospins
in 0.2% IGEPAL, 1% BSA (both Sigma-Aldrich, Steinheim,
Germany), and 10% normal goat serum (NGS) (Biosera, East
Sussex, UK). Non-specific binding was blocked using 20% NGS/
5% BSA before endogenous strepavidin and biotin were blocked
per kit instructions (Vector Labs, Burlingame, CA). The mouse
monoclonal primary antibodies ERa (Vector Labs, Burlingame,
CA) and PR (Novocastra Laboratories, Newcastle upon Tyne, UK)
Isolation of Human Endometrial Stem Cell Lines
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were each diluted 1:20 in blocking serum and applied to cytospins
overnight at 4uC. The primary antibody was omitted on negative
control slides. A biotinylated goat anti-mouse secondary antibody
(1:500 dilution, Vector Labs, Burlingame, CA) followed by HRP-
conjugated strepavidin (1:1000 dilution, Vector Labs, Burlingame,
CA) were both applied for 30 minutes at room temp before addition
of the substrate diaminobenzidine per kit instructions (Vector Labs,
Burlingame, CA). The sections were counterstained in haematox-
ylin and mounted in pertex.
In vitro differentiation
The ICEp and ICEs lines were cultured in vitro with adipogenic
and osteogenic differentiation media. Normoxic conditions were
used to maintain the cells under differentiation protocols (18–20%
O2, 37uC, 5% CO2, 90% humidity). Both cell lines were treated
with the adipogenic induction media: h-insulin, L-Glutamine,
MCGS, Dexamethasone, Indomethacin, IBMX and Penicillin/
streptomycin (Lonza, Barcelona, Spain), and osteogenic induction
media: Dexamethasone, L-Glutamine, Ascorbate, MCGS, Peni-
cillin/streptomycin and b-Glycerophosphate (Lonza), during two-
three weeks according established manufacturer’s protocols. Cells
treated with the maintenance media were the negative control of
the differentiation process. Afterward, cells were fixed and the
adipogenic/osteogenic differentiation was detected by particular
staining and specific gene expression. In the adipogenic differen-
tiation procedure, Oil Red O staining and mRNA levels of specific
genes, such as lipoprotein lipase, were used to detect the presence
of lipid vacuoles [30]. For osteogenic differentiation, bone
sialoprotein (BSP, MAB1061, Chemicon International) immuno-
cytochemistry was performed and expression of osteoblast marker
Osterix [31,32] was measured at the mRNA level. RNA extraction
and real-time PCR were performed to ensure the differentiation
results. Our positive controls for Oil Red O and LPL expression
were adipocyte cells cultured from tissue explants. Positive controls
for bonesialoprotein expression and genes battery were osteocytes
removed from bone explants. In all cases, negative controls were
cultured endometrial cells.
Animal Model: Xenotransplantation assays
All procedures involving animals in this study were approved by
CIPF and Instituto Valenciano de Infertilidad (IVI) review board.
Female NOD-SCID mice (strain code 394; NOD. CB17-
Prkdcscid/NCrCrl from Charles River Laboratories, Spain) were
ovariectomized at 5–6 weeks and then used for xenotransplanta-
tion experiments. Subsequently, mice were anesthetized with
sevofluorane inhalation followed by kidney externalization
through a dorsal-horizontal incision for the cell injection. In order
to guarantee the optimal technical procedure, we performed this
procedure on two mice treated with the complete endometrial
fraction, as Masuda described in PNAS 2007 [33].
In our experimental approach, the single-cell suspensions
(200,000 to 1,000.000 cells) from ICEp and ICEs were
resuspended in 30 ml of medium (DMEMF-12, Sigma-Aldrich,
Spain) and injected under the kidney capsule. Negative controls
were injected using only medium. During transplantation,
estradiol pellets (SE121, 17b-estradiol 0.18 mg/60 days; Innova-
tive Research of America) were also implanted subcutaneously at
the neck. Moreover, some mice treated with estradiol pellets were
injected subcutaneously every day with 1 mg of progesterone (P
(P4), Dr. Carreras, Hospital14, Barcelona, Spain) for two weeks
within a 3-week interval. After this period, mice were subjected to
a second cycle of daily P4 injections for 2 weeks until they were
sacrificed. Animals were injected with ICEp, ICEs and ICE-
p+ICEs. Throughout this assay, xenotransplanted mice were
maintained in specified pathogen free (SPF) facilities and fed ‘‘ad
libitum’’ for 60 days after the injection. After that, mice were
nephrectomized according to the experimental protocol.
Results
SP isolation and generation of the endometrial SP
epithelial and stromal cell lines
We first isolated the SP population from both fractions of the
human endometrium as described in our previous work [26]. SP
represents 1.6860.27% of the total living cell population in the
epithelial fraction and 0.3960.06% of the stromal fraction.
The establishment of SP cell lines required the following steps.
SP cells isolated from both endometrial fractions were cultured at
clonal densities (20–200 cells/cm2) under hypoxic conditions for 2
weeks. The largest colonies, described as putative SSC [28], were
re-plated at least three times to purify the cell population obtained.
Subcultures were performed every 7–9 days and the generated cell
Table 1. List of primers used for cell line characterization.
Gene Fw 59-39 Rv 59-39 Characterization
Oct-4 AAGAACATGTGTAAGCTGCGGCCC GGAAAGGCTTCCCCCTCAGGGAAAGG Undifferentiation
Nanog GATTTGTGGGCCTGAAGAAA TGGGGTAGGTAGGTGCTGAG Undifferentiation
GDF3 CTTCACCCCAGAAGTTCCAA GCAGGTTGAAGTGAACAGCA Undifferentiation
GABR3 CTTGACAATCGAGTGGCTGA CAACCGAAAGCTCAGTGACA Undifferentiation
DNMT3B TTTGGCCACCTTCAATAAGC GGCAACATCTGAAGCCATTT Undifferentiation
WT1 TCCTTCATCAAACAGGAGCCGAGC CTGTAGGGCGTCCTCAGCAGCAAAG Mesoderm origin
Renin AGTCGTCTTTGACACTGGTTCGTCC GGTAGAACCTGAGATGTAGGATGC Mesoderm origin
Cardiac Actin TCTATGAGGGCTACGCTTTG CCTGACTGGAAGGTAGATGG Mesoderm origin
Enolase TGACTTCAAGTCGCCTGATGATCCC TGCGTCCAGCAAAGATTGCCTTGTC Mesoderm origin
d-Globin ACCATGGTGCATCTGACTCCTGAGG ACTTGTGAGCCAAGGCATTAGCCAC Mesoderm origin
AMY GCTGGGCTCAGTATTCCCCAAATAC GACGACAATCTCTGACCTGAGTAGC Endoderm Origin
NFH TGAACACAGACGCTATGCGCTCAG CACCTTTATGTGAGTGGACACAGAG Ectoderm origin
GAPDH TGAGCTGAACGGGAAGCTCA GTCTACATGGCAACTGTGAGGA Housekeeping
doi:10.1371/journal.pone.0021221.t001
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lines required a change of medium after 3–4 days. After 12 to 15
passages (7 to 9 days per passage) a total of seven human
endometrial SP cell lines were obtained (ICE1-7) and cryopre-
served. Four lines were from epithelium and 3 lines from stroma.
Two lines of epithelial origin (ICEp) corresponding to ICE1 and
ICE6, and two from the stromal compartment (ICEs) correspond-
ing to ICE2 and ICE7 were selected for full characterization.
Phenotype of endometrial SP lines
ICEp cell lines displayed typical epithelial, round morphology
(Figure 1A), whereas ICEs cells presented with a typical fibroblast-like
appearance (Figure 1C). Phenotypic analyses by flow cytometry
demonstrate that ICEp contained 76.6% CD9 positive cells and ICEs
contained 91.4% vimentin positive cells. In all cases mesenchymal
commitment was demonstrated by the expression of CD90, CD105,
and CD73. In the case of ICEp, the percentages obtained were
88.4% for CD90, 67.8% for CD105, and 93.3% for CD73. For ICEs
lines expression was 53.4% for CD90, 48.2% for CD73, with no
detection of CD105. Moreover, we corroborated the absence of
typical markers for hematopoietic (CD45 and CD34), endothelial
(CD31), bone marrow stromal (stro-1), and endothelial progenitors
(CD133) in all the cell lines analyzed (Figure 1B and 1D).
Karyotype, molecular characterization and telomerase
activity
After the establishment of putative endometrial somatic stem
cell (hESC) lines, a preliminary molecular characterization was
necessary to confirm their lineage, their cytogenetic integrity, and
undifferentiated status. The molecular profiling of ICEp revealed
the expression of genes characteristic of undifferentiated cells, such
as Oct-4 (Octamer-binding transcription factor 4), NANOG, GDF3 (Growth
differentiation factor-3), GABR3, DNMT3B (DNA (cytosine-5-)-methyl-
transferase 3 beta), as well as those associated with mesodermal
commitment: WT1 (Wilms tumor protein), REN (Renin), Cardiac actin,
ENO (Enolase) and d-GLOB (gamma globulin) (Figure 2A). ICEs also
expressed a similar panel of genes including NANOG, GDF3,
GABR3 and DNMT3B as well as the mesodermal genes WT1,
Cardiac actin and d-GLOB (Figure 2A). These cell lines did not
express either endodermal or ectodermal genes, such as AMY
(Amylase) and NFH (Neurofilament heavy chain). Importantly a normal
karyotype corresponding to 46XX was confirmed in ICEp and
ICEs at passages 8 to 9 (Figure 2B). The pattern of telomerase
activity in these lines indicated it was intermediate between the
human embryonic stem cell line (hESC) VAL-9 [29] and human
foreskin fibroblast (Figure 2C).
Figure 1. Morphology and phenotype of endometrial somatic stem cell lines (ICE lines). A. Epithelial cell line (ICEp). Upper panel shows
aspect of cell growth in hypoxic conditions with typical epithelial features as polygonal/cuboidal shape. Lower panel, expression patterns related flow
cytometric analysis confirms positive expression (highlighted in red) of ICEp for epithelial CD9 (76.6%) and for mesenchymal stem cell markers like
CD73 (93.3%), CD90 (88.4%) and CD105 (67.8%). Negative expression in ICEp was distinguished for stromal origin (Vimentin), hematopoietic stem cell
markers (CD45 and CD34), endothelial cells (CD31), bone marrow stromal (stro-1) and endothelial progenitors (CD133). B. Stromal cell line (ICEs).
Upper panel shows the confluence cell culture with fibroblast-like appearance in hypoxic conditions. Lower panel, expression patterns related flow
cytometric analysis confirms positive expression (highlighted in red) of ICEs for stromal Vimentin (91.4%) and for mesenchymal stem cell markers like
CD73 (48.2%) and CD90 (53.4%). Negative expression in ICEs was distinguished for epithelial origin (CD9), mesenchymal stem cell marker (CD105),
hematopoietic stem cell markers (CD45 and CD34), endothelial cells (CD31), bone marrow stromal (stro-1) and endothelial progenitors (CD133). In all
the cases mouse FITC-labeled IgG1 (Millipore), FITC-labeled IgG2b (Chemicon), APC-labeled IgG1 (Milteny Biotec), Alexa647-labeled IgM (Biolegend),
and PE-labeled IgG1(Abcam) were used as isotypic controls (black) for staining of endometrial somatic stem cell lines (ICEp and ICEs).
doi:10.1371/journal.pone.0021221.g001
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Figure 2. Molecular and cytogenetic characterization of ICE lines. A. Results from PCR assay demonstrated the expression of undifferentiated
genes in both cell lines (highlighted in figure by asterisk). In addition the absence of typical endoderm and ectoderm markers suggest their
commitment to mesenchymal lineage throughout the presence of mesoderm genes. To assess the integrity of the samples analysed GAPDH gene
expression was performed. ICEp: Epithelial somatic stem cell line; ICEs: Stromal somatic stem cell line; C+: hESC, human embryonic stem cell line (VAL-
9) and C2: water. B. Normal karyotypes 46XX were obtained in both cases. C. Telomerase activity associated with length of telomeres was performed
in order to known the undifferentiated status of the cell lines. Telomerase activity of positive control, VAL, showed a ladder of amplification products
with six base increments starting at 50 nucleotides. An intermediate telomerase pattern was observed in both cases in comparison with hESC (VAL-9)
and differentiated cell line (Fsk).
doi:10.1371/journal.pone.0021221.g002
Isolation of Human Endometrial Stem Cell Lines
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Immunoexpression of estrogen receptor alpha (ERa) and
progesterone receptor (PR)
Immunocytochemical studies were performed to determine
whether the SP cell lines generated expressed the sex steroid
receptors, ERa and PR. ERa was not detected in the cellular
suspensions analyzed from either ICEp or ICEs (Figure 3A). In
contrast, strong expression of ERa was observed in HTB22, a
commercial cell line derived from adenocarcinoma of human
mammary gland that served as a positive control. Furthermore,
PR was not detected in ICEp or ICEs (Figure 3B) although
Ishikawa cells treated with estradiol (E2) were immunopositive.
Adipogenic and osteogenic differentiation of SP cell lines
The ability to differentiate into different cell types from a
specific lineage is one of the features of SSC cells. We examined
the in vitro potential of the SP cell lines ICEp and ICEs to undergo
osteogenic and adipogenic differentiation. At passage 6, both cell
lines were further cultured in the presence of adipogenic or
osteogenic induction media (see Materials and Methods) in
normoxic conditions.
Adipogenic differentiation was assessed by the accumulation of
lipid droplets demonstrated by Oil Red staining in the cytoplasm of
differentiated cells. Positive staining for lipid vacuoles was confirmed
in the cytoplasm of all cells differentiated from ICEp and ICEs.
Moreover, at the molecular level adipogenic transformation was
demonstrated by the increased expression of lipoprotein lipase (LPL)
[30] (Figure 4A). Osteogenic differentiation was investigated by an
immunocytochemistry assay using the specific biochemical marker of
mineralized tissues, bonesialoprotein (BSP). It was also confirmed at
the molecular levels by the increased expression of osterix in both cell
lines (Figure 4B) [31,32]. Therefore, similar to the results obtained
with SP cells [26], ICEp and ICEs were able to differentiate in vitro
into adipocytes and osteocytes using standard protocols.
Reconstruction of human endometrial-like tissue from SP
cell lines in NOD-SCID mice
Single-cell suspensions composed by 200,000 to 1,000,000 cells
obtained from ICEp, ICEs or ICEp+ICEs at passage 6 were
injected under the kidney capsule of immunosuppressed mice
treated with E2 or E2+P (see Materials and Methods). Mice treated
with single cell suspensions (500,000 cells) of total endometrium
were used as the positive control of the experimental procedure
[33]. In all cases, the injection of ICEp, ICEs or ICEp+ICEs and
treatment of the host with E2, or E2+P resulted in the
Figure 3. Immunostaining for ERalpha and progesterone receptor on cytospins of ICE and control cell lines. Immunopositive staining
for ERalpha was detected in the nuclei of HTB222 cells (lower left panel, insets high magnification and negative control). Immunopositive staining for
progesterone receptor was detected in nuclei of Ishikawa cells grown in the presence of E2 (lower left panel, insets high magnification and negative
control). In both the positive contol (+ve) cell lines a proportion of the cell nuclei were immunonegative (*). No immunopositive cell nuclei were
detected in any of the ICEp or ICEs cell lines tested. All ICE cell cytospins were stained in parallel with the appropriate positive control cell line using
identical conditions.
doi:10.1371/journal.pone.0021221.g003
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reconstruction of endometrial-like tissue in the kidney capsule
(Figure 5A and 5C). The endometrial reconstruction was
uncertain in only one case of ICEp exposed to E2 (Figure 5C).
To further assess the human origin of the reconstructed endometrial
tissues, we performed immunohistochemical analysis of the kidney
capsules removed from all cell lines as well as cell lines with hormonal
Figure 4. In vitro differentiation of ICE lines into mesenchymal lineages. A. Upper panel, adipogenic differentiation assay was visualised by
the presence of Oil Red O staining in lipids vacuoles. Cells non-treated with differentiation media were included as control, being negative for Oil Red
staining. Adipocytes from culture explant were included as positive control. Lower box indicated over-expression of lipoprotein lipase at mRNA levels
in induced differentiated cells. B. Upper panel, osteogenic differentiation process was detected by the reactivity against bone sialoprotein. Cells non-
treated with differentiation media were included as control being negative for bone sialoprotein expression. Osteocytes from culture explant were
included as a positive control. Lower box shows over-expression of osterix mRNA in induced differentiated cells.
doi:10.1371/journal.pone.0021221.g004
Isolation of Human Endometrial Stem Cell Lines
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treatment using human vimentin Figure 5B), human CD9, human
progesterone receptor, and human CD31 with proper controls (see
Figure 6). Results are presented in Figure 6 and summarized in
Figure 5C. The results demonstrated that endometrial SP lines were
capable of reconstructing total human endometrium determined by
the presence of human vimentin and CD9 positive cells in the renal
capsule. We further confirmed the expression of human progesterone
receptor (PR) in all the xenografts obtained from animals treated with
E2+P. Interestingly, in the endometrial-like tissue obtained in animals
treated with E2 alone after the injection of cells from ICEp+ICEs the
expression of PR was also detected. As expected, human endothelial
marker hCD31 was not detected in endometrial-like tissue suggesting
that the neovascularization derived from host.
Discussion
The results of this study extend and confirm our previous
finding suggesting that endometrial SP cells from both the stromal
and epithelial compartment are putative human endometrial stem
cells [26]. Here, we demonstrated that human endometrial SP
(hESP) lines expressed markers characteristic of undifferentiated
cells together with those of typical of cells committed to a
mesodermal lineage. Notably these cells were able to differentiate
into both adipocytes and osteocytes in vitro, and to give rise to
endometrial-like tissue in vivo. We have demonstrated that hESP
cells do not express ERa and PR and thus will be unresponsive to
sex steroid action mediated via these two steroid receptors.
Due to the absence of specific markers for endometrial stem
cells, we have used a two-step process for derivation of human
endometrial SP cell lines. The first process is based on the Side
Population (SP) method that relies on the capability of cells to
extrude the DNA binding dye Hoechst 33342 via the ATP-
binding cassette [17,18]. This method has been used for the
identification of putative SSC in skin [20], myometrium [21], lung
[22], dental pulp [23] and endometrium [24–27]. Utilisation of a
cloning efficiency method [6] under hypoxic conditions [26] has
Figure 5. Reconstruction of human endometrial-like tissue from ICE lines. A. Macroscopic and microscopic visualisation of the transplanted site
(arrow). H&E staining to assess the presence of endometrial reconstruction in the murine kidney after 60 days of xenotransplantation. B. Pictures showing
some results for human vimentin protein expression (green fluorescence signal) in mice treated with P4 and injected with stromal (ICEs) and
epithelial+stromal (ICEp+ICEs) cell lines. Nuclei stainedwithDAPI (blue fluorescence signal) and autofluorescence of kidney cells (red fluorescence signal) are
shown. C. Table summarizing the results of the samples analysed. In the first column H&E results concerning visual analysis are assigned as + (reconstructed
endometrial tissue), ++ (high appearance of endometrial-like tissue) and +/2 (poor observation of reconstructed tissue) in all themice injected with human
cells. Serial markers for immunohistochemistry assays (hVimentin, hCD9, hCD31 and PR) were performed in a subset of mice injected with total
endometrium, ICEp, ICEs, ICEp+ICEs, ICEp+P4, ICEs+P4 and ICEp+ICEs+P4. Note positive expression is indicated as + and negative expression as 2.
doi:10.1371/journal.pone.0021221.g005
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been undertaken to further select the subpopulation that gives rise
to hESP lines. The hypoxic environment has been considered
essential to maintain SP cells derived from bone marrow [34] and
to enhance the proliferation of somatic stem cells [35,36].
Using these selection criteria four hESP lines were established
from epithelial compartment (ICEp lines 1-3-5-6) and three from
the stromal compartment (ICEs, lines 2-4-7). Two ICEp and two
ICEs were selected for full characterization and were shown to
maintain a stable 46XX karyotype. Epithelial (CD9) and stromal
(vimentin) cell markers confirmed their respective epithelial or
stromal origin, and the additional demonstration of homogenous
expression of WT1, cardiac actin, and d-GLOB further suggested
their mesenchymal origin [10,26].
The coexistence of undifferentiated markers with those of
mesodermal origin in the absence of ectoderm or endoderm
differentiation genes have been identified in other cell types, such
Figure 6. Immunohistochemical analysis of endometrial xenografts from mice. Panel summarizing the immunohistochemical analysis for
hvimentin, hCD9, hCD31 and PR in endometrial-like tissues obtained after the injection of total endometrial cell suspensions (End=positive control of
the cellular injection procedure) treated with E2, putative epithelial somatic stem cell lines from human endometrium (ICEp) treated with E2 and E2+P,
putative stromal somatic stem cell lines from human endometrium (ICEs) treated with E2 and E2+P and ICEp+ICEs treated with E2 and E2+P. Human
endometrial tissue sections were used as positive controls for all the antibodies described above (upper section of the panel).
doi:10.1371/journal.pone.0021221.g006
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as adipose-derived stem cells [37,38] and adult bone marrow-
derived stem cells [39]. Our hESP cell lines, like other adult-
derived stem cells described previously, not only co-expressed
mesenchymal and differentiated markers at protein and molecular
levels, but also demonstrated the capability to differentiate into
mesodermal specific lineages such adipocytes and osteocytes when
exposed to appropriate conditions.
Estrogen regulates endometrial cell survival, viability and
mitogenic effects via ERa, the predominant endometrial estrogen
receptor [40]. ERb is expressed in multiple cell populations
throughout the human endometrium [41] and studies in mice
suggest it may have a negative impact on Era mediated responses
[42]. Mouse PR knockout studies indicate that the anti-
proliferative effect of progesterone on endometrial epithelium is
mediated by the PR-A isoform [43]. ICEp and ICEs did not
express ERa or PR. This finding is in agreement with a report that
ERa was not expressed in putative endometrial stem/progenitor
cells identified using the label retaining cell (LRC) mouse model in
which slow-cycling (putative stem cells) were identified by injection
of bromodeoxyuridine [1]. In this study Chan and Gargett
immunolocalised ERa to the nuclei of differentiated epithelial and
stromal cells but found that epithelial LRC were ERa negative
although a small population (16%) of stromal LRC did express
ERa. A recent study has reported that, at least in mice, estrogen-
induced proliferation of uterine epithelium is not mediated by
expression of ERa [44] a finding in agreement with earlier studies
using tissue recombinants that reported estrogen regulates
endometrial epithelial proliferation through paracrine signaling
involving ERa positive stromal cells [45]. Notably in both
primates and mouse models during endometrial breakdown and
early repair ERa is expressed in stromal but not in epithelial cells
supporting the notion that the stromal compartment plays the key
role in the orchestration of normal endometrial reconstruction in
response to estrogen [46,47].
Although ERa and PR were not detected in the hESP lines
when these cells were injected into immunocompromised mice the
stromal cells were able respond to exogenous E2 and P and the
human epithelial cell layer formed in the reconstructed endome-
trium expressed PR (Figure 5). Therefore, we hypothesize that
signals coming from the stem cell niche may maintain the SSC
population in a hormonally naı¨ve state and that they become
responsive to steroids after differentiating into transient amplifying
cells.
We have also shown that hESP cell lines retain the capability to
differentiate in vitro into different mesodermal lineages, including
adipocytes and osteocytes [26]. The key achievement of the
current study was our ability to demonstrate that, when injected
into the renal capsule of immunodeficient mice (NOD-SCID),
hESP lines consistently generated endometrial human tissue.
Notably, we have injected ICEp or ICEs lines both separately or in
combination (ICEp+ICEs) into animals that were subsequently
treated with E2 alone or E2+P. All cases (except one) this regimen
resulted in the reconstruction of endometrial-like tissue in the
kidney capsule (Fig. 5A, 5B and 6) that was also further
characterized for the expression of human vimentin, hCD9,
hCD31 and PR (Figure 5C and 6) resulting in the following
findings. First, human endometrium could be regenerated from
hESP lines obtained from the epithelial (ICEp) as well as from the
stromal (ICEs) compartments. Second, the sequential treatment
with E2+P was superior in terms of the amount of reconstructed
endometrium produced. Finally, the vasculature of the newly
formed endometrium was derived from the host since hCD31 was
not detected in any of the xenografts analyzed.
In conclusion, we demonstrate that in vitro differentiation to
adipocytes and osteocytes, as well as in vivo formation of
endometrial-like tissue, can be obtained after renal capsule
injection of cells from hESP lines that are chromosomally normal,
ERa and PR negative, and committed to a mesoderm lineage.
Therefore, we have demonstrated that hESP cell lines display
similar phenotypic, molecular signatures, in vitro and in vivo
differentiation capabilities as ‘‘primary’’ endometrial SP cells
[26], creating a reliable in vitro model to test relevant targets for
endometrial physiology and pathology.
The limitations however of the present study are that the hESP
lines created have a limited number of passages, usually the total
culture period is about 20 weeks, after which they cease to
proliferate effectively. The next step is to further refine the model
focusing on specific markers and mechanisms.
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